In a phase I/IIa study by Miriam et al., 24 patients with advanced HPV-associated cancer, including 6 with HNSCC, received vaccination with the p16(INK4a)-derived peptide P16_37-63. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.